COVID-19 and the newly rediscovered multidisciplinarity.

Bersanelli, Melissa

Bersanelli, Melissa.

Bersanelli M; Department of General and Specialistic Medicine, University Hospital of Parma, Medical Oncology Unit, Parma, Italy.

Immunotherapy ; 12(15): 1101-1103, 2020 10.

Article in English | MEDLINE | ID: covidwho-789123

Subject(s)

Coronavirus Infections/therapy; Interdisciplinary Research; Pneumonia, Viral/therapy; Anticoagulants/therapeutic use; Betacoronavirus; COVID-19; Coronavirus Infections/epidemiology; Coronavirus Infections/immunology; Coronavirus Infections/prevention & control; Humans; Immunocompromised Host; Immunologic Factors/therapeutic use; Immunotherapy; Pandemics/prevention & control; Pneumonia, Viral/epidemiology; Pneumonia, Viral/immunology; Pneumonia, Viral/prevention & control; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; anti-PD-1/PD-L1; immunosuppressed; immunotherapy; janus kinase inhibitors; pandemic; tocilizumab; virus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Interdisciplinary Research Type of study: Observational study Limits: Humans Language: English Journal: Immunotherapy Journal subject: Allergy and Immunology / Therapeutics Year: 2020 Document Type: Article Affiliation country: Imt-2020-0205

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google